XML 40 R80.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:                
Net loss including non-controlling interests $ 30,311 $ 51,174 $ (107,978) $ 66,223 $ (316,301) $ 3,712 $ (26,493) $ (246,366)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:                
Equity in earnings (loss) of subsidiaries 0     0     0 0
Depreciation, depletion and amortization 210,832     162,984     578,023 465,819
Loss on extinguishment of debt 0     47     0 13,698
(Gain) loss on sale of properties 752     (36,869)     3,950 (38,823)
Impairment 0     0     653 384,228
Deferred income taxes             (8,840) (75,418)
Derivative instruments (47,922)     48,544     34,940 239,945
Equity-based compensation expenses             26,370 21,586
Deferred financing costs amortization and other             18,190 20,074
Working capital and other changes:                
Change in accounts receivable, net             1,555 (61,275)
Change in inventory             (3,676) (12,076)
Change in prepaid expenses             4,153 1,196
Change in accounts payable, interest payable and accrued liabilities             22,280 50,308
Change in other assets and liabilities, net             (11,211) (895)
Net cash provided by operating activities             639,894 762,001
Cash flows from investing activities:                
Capital expenditures             (714,270) (841,088)
Acquisitions             (8,337) (579,886)
Proceeds from sale of properties             41,039 333,029
Derivative settlements             10,752  
Costs related to sale of properties             0 (2,707)
Derivative settlements               (162,013)
Other             0 (1,038)
Net cash used in investing activities             (670,816) (1,253,703)
Cash flows from financing activities:                
Proceeds from Revolving Credit Facilities             1,651,000 2,499,000
Principal payments on revolving credit facility             (1,600,000) (1,959,000)
Repurchase of senior unsecured notes             0 (423,190)
Proceeds from issuance of senior unsecured notes             0 400,000
Deferred financing costs             (852) (7,650)
Purchases of treasury stock             (4,625) (6,806)
Distributions to non-controlling interests             (15,551) (10,393)
Investment in subsidiaries / capital contributions from parent             0 0
Payments on finance lease liabilities             (1,423) 0
Other             (392) (87)
Net cash provided by financing activities             28,157 491,874
Increase (decrease) in cash and cash equivalents             (2,765) 172
Beginning of period     22,190     16,720 22,190 16,720
End of period 19,425     16,892     19,425 16,892
Intercompany Eliminations                
Cash flows from operating activities:                
Net loss including non-controlling interests (100,034)     (131,508)     (161,450) 52,353
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:                
Equity in earnings (loss) of subsidiaries 97,072     129,657     153,688 (58,606)
Depreciation, depletion and amortization (5,140)     (4,048)     (15,263) (11,017)
Loss on extinguishment of debt       0       0
(Gain) loss on sale of properties 0     0     0 0
Impairment             0 0
Deferred income taxes             0 0
Derivative instruments 0     0     0 0
Equity-based compensation expenses             0 0
Deferred financing costs amortization and other             0 0
Working capital and other changes:                
Change in accounts receivable, net             (101,262) 234,798
Change in inventory             0 0
Change in prepaid expenses             0 0
Change in accounts payable, interest payable and accrued liabilities             101,262 (234,798)
Change in other assets and liabilities, net             0 0
Net cash provided by operating activities             (23,025) (17,270)
Cash flows from investing activities:                
Capital expenditures             0 0
Acquisitions             0 0
Proceeds from sale of properties             0 0
Derivative settlements             0  
Costs related to sale of properties               0
Derivative settlements               0
Other               0
Net cash used in investing activities             0 0
Cash flows from financing activities:                
Proceeds from Revolving Credit Facilities             0 0
Principal payments on revolving credit facility             0 0
Repurchase of senior unsecured notes               0
Proceeds from issuance of senior unsecured notes               0
Deferred financing costs             0 0
Purchases of treasury stock             0 0
Distributions to non-controlling interests             54,116 92,672
Investment in subsidiaries / capital contributions from parent             (31,091) (75,402)
Payments on finance lease liabilities             0  
Other             0 0
Net cash provided by financing activities             23,025 17,270
Increase (decrease) in cash and cash equivalents             0 0
Beginning of period     0     0 0 0
End of period 0     0     0 0
Parent/ Issuer                
Cash flows from operating activities:                
Net loss including non-controlling interests 20,288     62,341     (51,837) (257,273)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:                
Equity in earnings (loss) of subsidiaries (54,755)     (96,555)     (39,118) 149,295
Depreciation, depletion and amortization 0     0     0 0
Loss on extinguishment of debt       47       13,698
(Gain) loss on sale of properties 0     0     0 0
Impairment             0 0
Deferred income taxes             (23,431) (26,351)
Derivative instruments 0     0     0 0
Equity-based compensation expenses             13,933 20,292
Deferred financing costs amortization and other             12,582 11,955
Working capital and other changes:                
Change in accounts receivable, net             94,214 (227,589)
Change in inventory             0 0
Change in prepaid expenses             283 (350)
Change in accounts payable, interest payable and accrued liabilities             (13,684) (12,270)
Change in other assets and liabilities, net             0 0
Net cash provided by operating activities             (7,058) (328,593)
Cash flows from investing activities:                
Capital expenditures             0 0
Acquisitions             0 0
Proceeds from sale of properties             0 0
Derivative settlements             0  
Costs related to sale of properties               0
Derivative settlements               0
Other               0
Net cash used in investing activities             0 0
Cash flows from financing activities:                
Proceeds from Revolving Credit Facilities             0 0
Principal payments on revolving credit facility             0 0
Repurchase of senior unsecured notes               (423,190)
Proceeds from issuance of senior unsecured notes               400,000
Deferred financing costs             0 (7,058)
Purchases of treasury stock             (4,625) (6,806)
Distributions to non-controlling interests             0 0
Investment in subsidiaries / capital contributions from parent             11,649 365,601
Payments on finance lease liabilities             0  
Other             0 38
Net cash provided by financing activities             7,024 328,585
Increase (decrease) in cash and cash equivalents             (34) (8)
Beginning of period     179     178 179 178
End of period 145     170     145 170
Combined Guarantor Subsidiaries                
Cash flows from operating activities:                
Net loss including non-controlling interests 54,755     96,555     39,118 (149,295)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:                
Equity in earnings (loss) of subsidiaries (42,317)     (33,102)     (114,570) (90,689)
Depreciation, depletion and amortization 206,989     159,843     566,812 456,624
Loss on extinguishment of debt       0       0
(Gain) loss on sale of properties 752     (36,869)     3,950 (38,823)
Impairment             653 384,228
Deferred income taxes             14,591 (49,067)
Derivative instruments (47,922)     48,544     34,940 239,945
Equity-based compensation expenses             12,134 1,014
Deferred financing costs amortization and other             4,948 7,884
Working capital and other changes:                
Change in accounts receivable, net             9,858 (77,231)
Change in inventory             (3,676) (12,076)
Change in prepaid expenses             3,416 864
Change in accounts payable, interest payable and accrued liabilities             (63,125) 278,481
Change in other assets and liabilities, net             (9,258) (895)
Net cash provided by operating activities             499,791 950,964
Cash flows from investing activities:                
Capital expenditures             (543,420) (621,269)
Acquisitions             (8,337) (579,886)
Proceeds from sale of properties             41,039 333,029
Derivative settlements             10,752  
Costs related to sale of properties               (2,707)
Derivative settlements               (162,013)
Other               (1,038)
Net cash used in investing activities             (499,966) (1,033,884)
Cash flows from financing activities:                
Proceeds from Revolving Credit Facilities             1,533,000 2,376,000
Principal payments on revolving credit facility             (1,595,000) (1,924,000)
Repurchase of senior unsecured notes               0
Proceeds from issuance of senior unsecured notes               0
Deferred financing costs             (41) (261)
Purchases of treasury stock             0 0
Distributions to non-controlling interests             0 0
Investment in subsidiaries / capital contributions from parent             62,824 (372,621)
Payments on finance lease liabilities             (1,364)  
Other             2 (125)
Net cash provided by financing activities             (579) 78,993
Increase (decrease) in cash and cash equivalents             (754) (3,927)
Beginning of period     15,362     15,659 15,362 15,659
End of period 14,608     11,732     14,608 11,732
Combined Non-guarantor                
Cash flows from operating activities:                
Net loss including non-controlling interests 55,302     38,835     147,676 107,849
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:                
Equity in earnings (loss) of subsidiaries 0     0     0 0
Depreciation, depletion and amortization 8,983     7,189     26,474 20,212
Loss on extinguishment of debt       0       0
(Gain) loss on sale of properties 0     0     0 0
Impairment             0 0
Deferred income taxes             0 0
Derivative instruments 0     0     0 0
Equity-based compensation expenses             303 280
Deferred financing costs amortization and other             660 235
Working capital and other changes:                
Change in accounts receivable, net             (1,255) 8,747
Change in inventory             0 0
Change in prepaid expenses             454 682
Change in accounts payable, interest payable and accrued liabilities             (2,173) 18,895
Change in other assets and liabilities, net             (1,953) 0
Net cash provided by operating activities             170,186 156,900
Cash flows from investing activities:                
Capital expenditures             (170,850) (219,819)
Acquisitions             0 0
Proceeds from sale of properties             0 0
Derivative settlements             0  
Costs related to sale of properties               0
Derivative settlements               0
Other               0
Net cash used in investing activities             (170,850) (219,819)
Cash flows from financing activities:                
Proceeds from Revolving Credit Facilities             118,000 123,000
Principal payments on revolving credit facility             (5,000) (35,000)
Repurchase of senior unsecured notes               0
Proceeds from issuance of senior unsecured notes               0
Deferred financing costs             (811) (331)
Purchases of treasury stock             0 0
Distributions to non-controlling interests             (69,667) (103,065)
Investment in subsidiaries / capital contributions from parent             (43,382) 82,422
Payments on finance lease liabilities             (59)  
Other             (394) 0
Net cash provided by financing activities             (1,313) 67,026
Increase (decrease) in cash and cash equivalents             (1,977) 4,107
Beginning of period     $ 6,649     $ 883 6,649 883
End of period $ 4,672     $ 4,990     $ 4,672 $ 4,990